Ellington Management Group’s Evolent Health EVH Stock Holding History

Ellington Management Group’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-34,800	Closed	-$857K	–	612
2016 Q3	$857K	Buy	+34,800	New	+$813K	0.24%	95
2016 Q2	–	Sell	-38,600	Closed	-$408K	–	323
2016 Q1	$408K	Buy	+38,600	New	+$399K	0.18%	163

Other funds holding EVH

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Ellington Management Group's EVH Position: Q4 2016 in Review

Ellington Management Group sold out of Evolent Health (EVH) in Q4 2016, closing a stake of 34,800 shares — an estimated $857K sold.

Ellington Management Group first reported a position in EVH in Q1 2016 and held it in 2 quarters. The position peaked at $857K in Q3 2016. 118 funds tracked by Wall St. Rank hold EVH as of Q4 2016.

Ellington Management Group reported no remaining Evolent Health position as of Q4 2016 after selling out during the quarter.
Ellington Management Group sold 34,800 Evolent Health shares in Q4 2016, an estimated $857K.
Ellington Management Group first reported a position in Evolent Health in Q1 2016 and held it in 2 quarters.
Ellington Management Group's Evolent Health position peaked at $857K in Q3 2016.
118 funds tracked by Wall St. Rank held Evolent Health as of Q4 2016.

Based on Ellington Management Group's 13F filing for Q4 2016, filed 14 Feb 2017.